Improving our ability to diagnose Hemoglobinopathies.

1. Oktober 2018

Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University...

Read more

ISO 15189. We made it.

11. September 2018

ARCHIMEDlife, a new global player for laboratory diagnostics for Rare Disorders and other niche diagnostic services, receives ISO 15189...

Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

7. März 2018

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...

Read more

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

21. November 2017

The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...

Read more

Become part of our readers´ community

12. November 2017

You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

We were there: Asia-Pacific Conference on Human Genetics

6. November 2017

We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to...

Read more

Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

16. Oktober 2017

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...

Read more

Our new Website is online!

1. September 2017

WELCOME! We are happy to announce that our new website is online. From now on you can find all...

Read more

Now published: A consensus guideline for newborn screening by mass spectrometry

25. Juli 2017

An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening...

Read more